$3.06
-0.005-0.16%
Last update: Dec 15, 12:34 PM
Comments
Loading...
Oramed Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:ORMP | Benzinga
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 13
EPS
$1.260
Quarterly Revenue
$2.00M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$2.00M
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
Oramed Pharmaceuticals (ORMP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-11-13 | $1.26 | $-0.08 | 1675.0 % |
| Q2 | 2025-08-14 | $0.13 | $-0.04 | 425.0 % |
| Q1 | 2025-05-15 | $-0.19 | $-0.05 | -280.0 % |
| Q4 | 2025-03-27 | $-0.26 | $-0.07 | -271.4 % |
Oramed Pharmaceuticals (ORMP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-15 | $2.00M | $500.00K | 300.0 % |
| Q2 | 2024-08-16 | $0 | $250.00K | -100.0 % |
| Q3 | 2023-11-09 | $0 | $700.00K | -100.0 % |
| Q2 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
FAQ
When is Oramed Pharmaceuticals (NASDAQ:ORMP) reporting earnings?
Oramed Pharmaceuticals (ORMP) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3.
What were the latest earnings per share (EPS) for Oramed Pharmaceuticals (NASDAQ:ORMP)?
Oramed Pharmaceuticals (ORMP) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3 and the Actual EPS was $1.26, which beat the estimate of $-0.08.
What were Oramed Pharmaceuticals’s (NASDAQ:ORMP) revenues?
Oramed Pharmaceuticals (ORMP) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 13, 2025 for Q3 and the Actual Revenue was $2M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
